Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.
The global immunomodulator industry is dominated by the North America region. Immunomodulator are used to regulate the immunity system. They alter the reaction of the immune system by changing the production of antibody cells. Diseases such as asthma, cancer, allergic conditions, sclerosis, Crohn’s disease and ulcerative colitis, among others, increases the demand for end-users immunomodulator-based treatment and high therapy cost associated with treatments are anticipated to drive revenue growth in the market. Factors contributing to the growth of immunomodulator market include infectious diseases primarily considered immunological disorders, organ transplantation, increasing adoption of an early immunomodulator therapy, rising awareness about inflammatory bowel diseases, growing autoimmune disease, and the increasing development of drug resistance resulting in rise of immunomodulatory usage. There are lucrative opportunities for the immunomodulator industry in developing nations due to unfulfilled clinical needs and lack of healthcare service delivery. Government is taking initiatives to increase awareness among the public regarding the benefits of immunomodulators.
Immunomodulators are becoming a viable adjunct to established modalities offering a completely unique approach for the treatment of communicable disease within the coming decades of 21st century. However, some drugs can cause fatigue, drowsiness, blood clotting and low blood pressure, amongst others. It can cause several birth defects, if consumed during gestation. The COVID-19 positively impacted the growth of immunomodulator market in the historical period. Due to outflow in the sale of emergency products, pharmaceutical companies are trying to maintain their supply chain, investing more in research and development, quality control, supply chain and operations management, fuelling the growth of the immunomodulator industry.
The rising competition among the key players is also providing an impetus to the market growth. In September 2021, Abbott Laboratories (NYSE: ABT) announced the acquisition of Walk Vascular, LLC, a commercial-stage medical device company with a minimally invasive mechanical aspiration thrombectomy system designed to remove peripheral blood clots. The acquisition fits well into their leading vascular device offerings and further drives Abbott's ability to provide one-of-a-kind endovascular therapy solutions to improve patient care.
Market Analysis by Products, Applications, and Regions:
Key Findings of the Report:
Key Offerings of the report:
The major players in the global immunomodulator industry are F. Hoffmann-La Roche Ltd., Amgen, Inc., Abbott Laboratories, Novartis AG, and Biogen Inc., amongst others. The comprehensive report by EMR looks into the market share, capacity, and latest developments like mergers and acquisitions, plant turnarounds, and capacity expansions of the major players.
Expert Market Research (EMR) is a leading market research and business intelligence company, ensuring its clients remain at the vanguard of their industries by providing them with exhaustive and actionable market data through its syndicated and custom market reports, covering over 15 major industry domains. The company's expansive and ever-growing database of reports, which are constantly updated, includes reports from industry verticals like chemicals and materials, food and beverages, energy and mining, technology and media, consumer goods, pharmaceuticals, agriculture, and packaging.
EMR leverages its state-of-the-art technological and analytical tools, along with the expertise of its highly skilled team of over 100 analysts and more than 3000 consultants, to help its clients, ranging from Fortune 1000 companies to small and medium sized enterprises, easily grasp the expansive industry data and help them in formulating market and business strategies, which ensure that they remain ahead of the curve.
Expert Market Research
US & Canada Phone no: +1-415-325-5166
UK Phone no: +44-702-402-5790
*We at Expert Market Research always strive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.